1. Home
  2. IMAB vs GDO Comparison

IMAB vs GDO Comparison

Compare IMAB & GDO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMAB
  • GDO
  • Stock Information
  • Founded
  • IMAB 2014
  • GDO 2009
  • Country
  • IMAB United States
  • GDO United States
  • Employees
  • IMAB N/A
  • GDO N/A
  • Industry
  • IMAB Biotechnology: Pharmaceutical Preparations
  • GDO Finance Companies
  • Sector
  • IMAB Health Care
  • GDO Finance
  • Exchange
  • IMAB Nasdaq
  • GDO Nasdaq
  • Market Cap
  • IMAB 79.9M
  • GDO 84.5M
  • IPO Year
  • IMAB 2020
  • GDO N/A
  • Fundamental
  • Price
  • IMAB $0.96
  • GDO $11.47
  • Analyst Decision
  • IMAB Strong Buy
  • GDO
  • Analyst Count
  • IMAB 3
  • GDO 0
  • Target Price
  • IMAB $8.00
  • GDO N/A
  • AVG Volume (30 Days)
  • IMAB 288.7K
  • GDO 39.4K
  • Earning Date
  • IMAB 03-13-2025
  • GDO 01-01-0001
  • Dividend Yield
  • IMAB N/A
  • GDO 9.81%
  • EPS Growth
  • IMAB N/A
  • GDO N/A
  • EPS
  • IMAB N/A
  • GDO N/A
  • Revenue
  • IMAB $3,313,984.00
  • GDO N/A
  • Revenue This Year
  • IMAB N/A
  • GDO N/A
  • Revenue Next Year
  • IMAB N/A
  • GDO N/A
  • P/E Ratio
  • IMAB N/A
  • GDO N/A
  • Revenue Growth
  • IMAB N/A
  • GDO N/A
  • 52 Week Low
  • IMAB $0.84
  • GDO $11.21
  • 52 Week High
  • IMAB $2.00
  • GDO $13.04
  • Technical
  • Relative Strength Index (RSI)
  • IMAB 45.33
  • GDO 61.08
  • Support Level
  • IMAB $0.95
  • GDO $11.33
  • Resistance Level
  • IMAB $1.04
  • GDO $11.49
  • Average True Range (ATR)
  • IMAB 0.06
  • GDO 0.08
  • MACD
  • IMAB -0.01
  • GDO 0.02
  • Stochastic Oscillator
  • IMAB 19.88
  • GDO 90.00

About IMAB I-MAB

I-MAB is a clinical-stage biotech company. Along with its subsidiaries, it is principally engaged in discovering and developing transformational biologics in the fields of immuno-oncology and immuno-inflammation diseases in the People's Republic of China and other countries and regions. Its drug pipeline includes Uliledlimab (TJD5) which is an antibody for solid tumors, Ragistomig (TJ-L14B), and Givastomig (TJ-CD4B).

About GDO Western Asset Global Corporate Defined Opportunity Fund Inc.

Western Asset Global Corp Defined Opp is a closed-end management investment company with a primary investment objective to provide current income. Its secondary objective is to seek capital appreciation. The Fund invests in the United States and foreign corporate fixed-income securities of varying maturities.

Share on Social Networks: